Butterfly Network Joins Global Congenital Heart Disease Alliance to Deploy Four AI Imaging Units
BFLY•Butterfly Network joined the Global Congenital Heart Disease Alliance alongside Ventripoint and other imaging firms, which plans to deploy four Ventripoint VMS+ cardiac imaging units in underserved regions. The consortium’s global reach could accelerate adoption of Butterfly’s handheld ultrasound devices for complex congenital heart diagnostics in emerging markets.
1. Butterfly Network Joins GCHDA
Butterfly Network has become a founding member of the Global Congenital Heart Disease Alliance, a consortium that brings together imaging companies, clinicians, researchers and patient groups to advance congenital cardiovascular technologies.
2. Deployment of Ventripoint VMS+ Units
As part of its launch initiatives, the alliance will fund and place four Ventripoint VMS+™ AI-assisted cardiac imaging units in lower- and middle-income regions to expand access to advanced congenital heart diagnostics.
3. Implications for Butterfly’s Handheld Devices
By collaborating on a global platform focused on congenital heart disease, Butterfly Network could see increased visibility and accelerated adoption of its handheld ultrasound systems in emerging markets requiring point-of-care cardiac imaging solutions.
